---
title: "688553.SH (688553.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688553.SH/news.md"
symbol: "688553.SH"
name: "688553.SH"
parent: "https://longbridge.com/en/quote/688553.SH.md"
datetime: "2026-05-21T09:36:45.966Z"
locales:
  - [en](https://longbridge.com/en/quote/688553.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688553.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688553.SH/news.md)
---

# 688553.SH (688553.SH) — Related News

### [HUIYU PHARMACEUTICAL: 6.12% of shareholder shares have been provisionally frozen](https://longbridge.com/en/news/284717440.md)
*2026-04-30T07:35:35.000Z*
> HUIYU PHARMACEUTICAL announced that 25,919,400 shares (accounting for 6.12% of the total share capital) held by sharehol

### [Huilun Pharmaceutical pushes through the Hong Kong stock market with injuries: "COVID miracle drug" recedes, burdened by a loan of 650 million](https://longbridge.com/en/news/284100336.md)
*2026-04-26T05:39:11.000Z*
> HuiLun Pharmaceutical is attempting to resolve its financial difficulties through a Hong Kong IPO after the pandemic ben

### [HUIYU PHARMACEUTICAL: Shareholder Huang Ganyi plans to reduce holdings passively by no more than 1%](https://longbridge.com/en/news/283638608.md)
*2026-04-22T10:00:35.000Z*
> HUIYU PHARMACEUTICAL announced that shareholder Huang Ganyi holds 25,919,400 shares, accounting for 6.119%, of which 19,

### [HUIYU PHARMACEUTICAL: The clinical trial application for drugs by its wholly-owned subsidiary has been accepted](https://longbridge.com/en/news/283460824.md)
*2026-04-21T08:19:01.000Z*
> HUIYU PHARMACEUTICAL announced that recently, its wholly-owned subsidiary HUIYU HAIYUE received the "Acceptance Notifica

### [HUIYU PHARMACEUTICAL: Shareholders holding more than 5% of shares, totaling 19.6283 million shares, will be subject to judicial enforcement](https://longbridge.com/en/news/283110229.md)
*2026-04-17T08:10:45.000Z*
> HUIYU PHARMACEUTICAL announced that shareholder Huang Qianyi holds 25,919,400 shares of the company, accounting for 6.11

### [](https://longbridge.com/en/news/282304742.md)
*2026-04-10T07:13:42.000Z*
> According to data from the National Bureau of Statistics, in March 2026, the CPI rose by 1.0% year-on-year, and the PPI 

### [HUIYU PHARMACEUTICAL: Three products approved for launch in Germany, Spain, Belgium, and Pakistan](https://longbridge.com/en/news/282280363.md)
*2026-04-10T02:57:04.000Z*
> HUIYU PHARMACEUTICAL announced that its subsidiary recently received approvals from the drug regulatory authorities in G

### [HUIYU PHARMACEUTICAL products have obtained overseas listing approval](https://longbridge.com/en/news/282154241.md)
*2026-04-09T07:50:05.000Z*
> HUIYU PHARMACEUTICAL announced that its subsidiaries Seacross (Europe) Pharma Ltd. and Seacross Pharmaceuticals Ltd. rec

### [Midday Market Review on April 9: SSE Index Drops 0.73% in Half-Day, Computing Power Hardware Stocks Strengthen Against the Trend](https://longbridge.com/en/news/282128234.md)
*2026-04-09T03:30:51.000Z*
> At the midday close on April 9, the SSE Index fell 0.73%, the Shenzhen Index dropped 0.31%, and the ChiNext decreased by